Extens sells its stake in Discngine

Back Published on 23/12/2022

Extens announces the sale of its stake in Discngine to the Canadian Chemical Computing Group (CCG) after five years of successful collaboration.

Discngine, provides modelling software solutions for the pharmaceutical and life sciences sector to accelerate molecular research thanks to high-performance data acquisition and analysis tools. Discngine is a recognised expert in its field, with customers including some of the world's leading laboratories, and has established partnerships with leading software vendors to integrate its technology into global offerings.
« We are very happy to have accompanied Discngine during these five critical years of its development. We strongly believe in the potential of the simulation software market in this industry and in the relevance of Discngine's merger with the CCG Group and wish Eric Le Roux and his team every success in this new stage of their development. »